SCHEMBL1439343

SCHEMBL1439343

COCC1CC(OS(C)(=O)=O)CN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1439651 1.00 — —
SCHEMBL1440132 0.83 — —
SCHEMBL18349433 0.82 HTT (0.31) —
SCHEMBL1440010 0.75 NR1H2 (0.35) —
SCHEMBL26789869 0.75 NR1H2 (0.35) —
SCHEMBL1439328 0.75 NR1H2 (0.35) —
SCHEMBL9383870 0.75 NR1H2 (0.35) —
SCHEMBL3945766 0.75 MMP2 (0.35) —
SCHEMBL26086744 0.75 MMP2 (0.35) —
SCHEMBL3249508 0.75 MMP2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2473502-A1 HETEROARYL COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2012-07-11 — — EP disclosed
EP-2473499-A1 BIPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Novartis AG (CH) 2012-07-11 — — EP disclosed
WO-2011026911-A1 BIPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2011-03-10 — — WO disclosed
WO-2011026917-A1 HETEROARYL COMPOUNDS AS KINASE INHIBITORS NOVARTIS AG (CH) 2011-03-10 — — WO disclosed
Send feedback